CANTAB® was originally designed by researchers at the University of Cambridge and our Scientific Team have worked using CANTAB® in academic research for more than twenty years.
The CANTAB® bibliography is a result of this extensive research and currently contains more than 700 peer-reviewed articles, providing our tests with an unparalleled level of validation. More than 100 disorders have been investigated using CANTAB®, and data on more than 60 drugs have been published in academic studies.
Over 500 academic research organisations in more than 60 different countries around the world are among our clients, including National Institutes of Health, Harvard University, Mount Sinai School of Medicine, The Scripps Research Institute, Yale University, Stanford University, University of California, Berkeley, University of Chicago, University of California, Los Angeles, University of Pennsylvania, Duke University, University of California, San Diego, University of Washington, Johns Hopkins University, McGill University, University of Toronto, University of British Columbia, University of Tokyo, Kyoto University, Australian National University, University of Melbourne, University of Copenhagen, Karolinska Institutet, Utrecht University, University of Munich, University of Vienna, University of Ghent, University of Oslo, University of Basel, University of Helsinki, University of Cambridge, University College London, University of Oxford, Imperial College London, University of Manchester and many other world leading academic research institutions.